CONMED Corporation (CNMD)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
CONMED Corporation (CNMD) P/E Ratio & Valuation History
CONMED (CNMD) trades at 10.4x trailing earnings and 1.1x sales. Its P/E of 10.4x is below its 5-year median of 20.5x. Its forward P/E is 27.2x. The median P/E across 7 similar companies is 29.1x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 61.8% lower over the next year. Its free cash flow yield is 9.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 10.4x |
| Forward P/E | 27.2x |
| Price to sales | 1.1x |
| Price to book | 1.4x |
| EV/EBITDA | 10.3x |
| Price to FCF | 11.1x |
| EV/FCF | 16.9x |
| PEG | 1.8 |
| FCF yield | 9.0% |
Historical Medians
Against its 10-year medians, its P/E is 66.7% below 31.2x, its P/S is 52.2% below 2.3x and its P/B is 54.8% below 3.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 10.4x | 20.5x | 31.2x |
| P/S | 1.1x | 1.8x | 2.3x |
| P/B | 1.4x | 2.7x | 3.1x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 8.8x in 2025 to 51.9x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $40.60 | 8.8x | 0.9x | 1.2x |
| 2024 | $68.44 | 16.5x | 1.6x | 2.2x |
| 2023 | $109.51 | 31.7x | 2.7x | 4.1x |
| 2022 | $88.64 | 33.4x | 2.6x | 3.7x |
| 2021 | $141.76 | 44.2x | 4.2x | 5.9x |
| 2020 | $112.00 | 51.9x | 3.8x | 4.7x |
| 2019 | $111.83 | 42.2x | 3.4x | 4.8x |
| 2018 | $64.20 | 29.4x | 2.1x | 2.8x |
| 2017 | $50.97 | 26.8x | 1.8x | 2.3x |
| 2016 | $44.17 | 27.4x | 1.6x | 2.1x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CNMD
What is CNMD's forward P/E ratio?
CONMED has a forward P/E ratio of 27.2x.
Is CNMD stock overvalued?
GNG's valuation label for CNMD is Fairly valued. Its P/E of 10.4x compares with a median of 29.1x across 7 similar companies.
What is CNMD's price to sales ratio?
CONMED has a price to sales ratio of 1.1x.
What is CONMED's average P/E ratio over 5 years?
CONMED's median P/E over the last 5 years is 20.5x, from 60 month-end values through Oct 2026.
What is CNMD's PEG ratio?
CONMED has a PEG ratio of 1.8.
CNMD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts